Lumos Pharma (LUMO)
(Delayed Data from NSDQ)
$2.81 USD
-0.02 (-0.71%)
Updated Apr 30, 2024 03:57 PM ET
After-Market: $2.87 +0.06 (2.14%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/1/24 |
---|---|
Current Quarter | -1.21 |
EPS Last Quarter | -1.17 |
Last EPS Surprise | 0.85% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.80 |
Next Year | -2.00 |
EPS (TTM) | -4.19 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.51M | 20.26M | 21.03M | 20.60M |
# of Estimates | 1 | 2 | 2 | 2 |
High Estimate | 0.51M | 40.00M | 40.00M | 39.14M |
Low Estimate | 0.51M | 0.51M | 2.05M | 2.05M |
Year ago Sales | 0.69M | 0.53M | 2.05M | 21.03M |
Year over Year Growth Est. | -26.09% | 3,721.70% | 925.11% | -2.05% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.21 | -0.42 | -2.80 | -2.00 |
# of Estimates | 3 | 3 | 4 | 3 |
Most Recent Consensus | -1.22 | -1.26 | -2.93 | -1.80 |
High Estimate | -1.15 | 1.29 | -0.50 | -1.80 |
Low Estimate | -1.27 | -1.28 | -4.84 | -2.38 |
Year ago EPS | -0.89 | -1.09 | -4.18 | -2.80 |
Year over Year Growth Est. | -35.96% | 61.47% | 33.01% | 28.57% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 0 | 1 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 2 | 2 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.21 | -0.42 | -2.80 | -2.00 |
7 Days Ago | -1.21 | -0.42 | -2.80 | -2.00 |
30 Days Ago | -1.21 | -0.42 | -2.80 | -2.00 |
60 Days Ago | -1.17 | 0.07 | -3.09 | -2.86 |
90 Days Ago | -1.17 | 0.07 | -3.09 | -2.86 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.21 | -0.42 | -2.80 | -2.00 |
Zacks Consensus Estimate | -1.21 | -0.42 | -2.80 | -2.00 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.17 | -1.04 | -1.09 | -0.89 | NA |
Estimate | -1.18 | -1.10 | -1.06 | -1.12 | NA |
Difference | 0.01 | 0.06 | -0.03 | 0.23 | 0.07 |
Surprise | 0.85% | 5.45% | -2.83% | 20.54% | 6.00% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more